These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin, and prolactin secretion in man. Sowers JR; Glub MS; Eggena PH; Catania RA J Clin Endocrinol Metab; 1982 Jan; 54(1):121-6. PubMed ID: 7033264 [TBL] [Abstract][Full Text] [Related]
3. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes. García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430 [TBL] [Abstract][Full Text] [Related]
4. [Lack of effect of aging on dopaminergic inhibition of aldosterone and prolactin increase]. Preis P; Luger A; Templ H; Tragl HK; Geyer G Z Gerontol; 1985; 18(4):241-3. PubMed ID: 3901563 [TBL] [Abstract][Full Text] [Related]
5. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus. Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494 [TBL] [Abstract][Full Text] [Related]
6. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine. Carey RM; Thorner MO; Ortt EM J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305 [TBL] [Abstract][Full Text] [Related]
7. Dopaminergic Modulation of renin activity and aldosterone and prolactin secretion in the spontaneously hypertensive rat. Sowers JR; Sollars EG; Tuck ML; Asp ND Proc Soc Exp Biol Med; 1980 Sep; 164(4):598-603. PubMed ID: 6997889 [No Abstract] [Full Text] [Related]
8. Increased aldosterone levels in a model of type 2 diabetes mellitus. Fredersdorf S; Endemann DH; Luchner A; Heitzmann D; Ulucan C; Birner C; Schmid P; Stoelcker B; Resch M; Muders F; Riegger GA; Weil J Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):15-20. PubMed ID: 18726873 [TBL] [Abstract][Full Text] [Related]
9. [Plasma renin, aldosterone, and dopamine-beta-hydroxylase activity in hypertensive patients over 70 years of age (author's transl)]. Annat G; Vincent M; Tourniaire A; Sassard J Nouv Presse Med; 1980 Mar; 9(14):1035-6. PubMed ID: 6988803 [No Abstract] [Full Text] [Related]
10. [Vasopressin and renin-aldosterone system in patients with arterial hypertension]. Kasenova SL Klin Med (Mosk); 2002; 80(12):31-4. PubMed ID: 12638408 [TBL] [Abstract][Full Text] [Related]
13. Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients. Luchsinger A; Grilli M; Forte P; Morales E; Velasco M Int J Clin Pharmacol Ther; 1995 Sep; 33(9):509-12. PubMed ID: 8520809 [TBL] [Abstract][Full Text] [Related]
14. [Studies of the effect of bromocriptine on the serum prolactin, aldosterone and cortisol levels and plasma renin activity in patients with essential hypertension]. Hudziak G; Kuska J Pol Arch Med Wewn; 1988 Jul; 80(1):9-16. PubMed ID: 3078204 [No Abstract] [Full Text] [Related]
15. [Renin-angiotensin-aldosterone system in diabetes, arterial hypertension and orthostatic hypotension]. Khristov V; Maleeva A; Turkolev N Vutr Boles; 1980; 19(4):28-31. PubMed ID: 6998133 [No Abstract] [Full Text] [Related]
16. Treatment of macroprolactinoma with the new potent non-ergot D2-dopamine agonist quinagolide and effects on prolactin levels, pituitary function, an the renin-aldosterone system. Results of a clinical long-term study. Nickelsen T; Jungmann E; Althoff P; Schumm-Draeger PM; Usadel KH Arzneimittelforschung; 1993 Apr; 43(4):421-5. PubMed ID: 8098604 [TBL] [Abstract][Full Text] [Related]
17. Plasma renin activity, aldosterone and cortisol levels during physical exercise in essential hypertension. Ignatowska-Switalska H; Wocial B; Skórka B; Chodakowska J; Nazar K; Chwalbińska-Moneta J Acta Physiol Pol; 1980; 31(6):631-5. PubMed ID: 7018172 [TBL] [Abstract][Full Text] [Related]
18. [Aldosterone response to metoclopramide, a dopaminergic inhibitor, in normal men; evaluation of the mechanisms (author's transl)]. Mizuno K; Yamazaki M; Toki T; Ono Y; Hashimoto S; Yaginuma K; Nagasawa S; Fukuchi S Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):175-80. PubMed ID: 7047824 [No Abstract] [Full Text] [Related]
19. [Renin-aldosterone system in secretion of cortisol in patients with arterial hypertension in European North]. Iakovlev VA; Sokol LIu; Karlov VA Klin Med (Mosk); 1998; 76(1):35-7. PubMed ID: 9532913 [TBL] [Abstract][Full Text] [Related]
20. [Role of hypothalamo-hypophyseal-adrenal axis in the pathogenesis of arterial hypertension in patients with prolactinoma of the anterior lobe of the hypophysis]. Mychka VB; Chazova IE; Dmitriev VV; Masenko VP Ter Arkh; 2000; 72(9):10-3. PubMed ID: 11076407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]